Kim Van Naarden Braun
About Kim Van Naarden Braun
Kim Van Naarden Braun is the Senior Scientific Director of Translational Epidemiology, Informatics, and Predictive Sciences at Bristol Myers Squibb in New Jersey, with over 20 years of experience in epidemiology and a strong background in public health policy and research.
Title
Kim Van Naarden Braun holds the position of Senior Scientific Director, Translational Epidemiology, Informatics and Predictive Sciences at Bristol Myers Squibb. Her role involves spearheading initiatives in identifying translational and predictive science opportunities in the domain of epidemiology.
Company
Currently, Kim is working at Bristol Myers Squibb in New Jersey, United States. She has been involved with the company in various capacities since 2019, including roles as Scientific Director and Associate Director in Translational Epidemiology, Informatics and Predictive Sciences.
Education and Expertise
Kim earned her Doctor of Philosophy (PhD) in Epidemiology from Columbia University from 1999 to 2003. She also holds a Master of Public Health (MPH) in Epidemiology from Columbia University, completed from 1995 to 1997, and a Bachelor's degree in Public Health Policy with a minor in Chemistry from the University of Pennsylvania, completed between 1991 and 1995. She has over two decades of experience in designing and implementing large-scale epidemiologic surveillance and observational research studies.
Background
In addition to her work at Bristol Myers Squibb, Kim has an extensive background in epidemiology and public health. She has worked with the Centers for Disease Control and Prevention (CDC) in various roles, including Senior Epidemiologist and Team Lead, with a significant focus on neurodevelopmental disabilities. She has also held academic positions at the Hackensack Meridian School of Medicine at Seton Hall and served as a Senior Epidemiologist at Hackensack Meridian Health.
Achievements
Kim Van Naarden Braun is recognized nationally and internationally for her contributions to the epidemiology of neurodevelopmental disabilities. She is known for translating and communicating complex technical findings to diverse audiences. Additionally, she has demonstrated success in facilitating strategic partnerships and leading multidisciplinary teams with a collaborative management style.